Literature DB >> 19733302

Consistency of sputum eosinophilia in difficult-to-treat asthma: a 5-year follow-up study.

Ilonka H van Veen, Anneke Ten Brinke, Stefanie A Gauw, Peter J Sterk, Klaus F Rabe, Elisabeth H Bel.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19733302     DOI： 10.1016/j.jaci.2009.06.029

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  31 in total

1.  ATS Core Curriculum 2015. Part I: Adult Pulmonary Medicine.

Authors:  Gaëtane C Michaud; Colleen L Channick; Chad R Marion; Robert M Tighe; James A Town; Andrew M Luks; Jeremy B Richards; Sucharita Kher; Prerna Mota; Gina Hong; Natalie E West; Craig Rackley; Luke Neilans; Josanna Rodriguez-Lopez; Hilary DuBrock; Cassie C Kennedy; Diana J Kelm; Carey C Thomson
Journal:  Ann Am Thorac Soc       Date:  2015-09

Review 2.  Asthma phenotypes: the evolution from clinical to molecular approaches.

Authors:  Sally E Wenzel
Journal:  Nat Med       Date:  2012-05-04       Impact factor: 53.440

Review 3.  Anti-IL-5 Biologicals Targeting Severe Late Onset Eosinophilic Asthma.

Authors:  Leyla Pur Özyiğit; Ayşe Bilge Öztürk; Sevim Bavbek
Journal:  Turk Thorac J       Date:  2020-01-01

Review 4.  Biomarkers in Severe Asthma.

Authors:  Xiao Chloe Wan; Prescott G Woodruff
Journal:  Immunol Allergy Clin North Am       Date:  2016-08       Impact factor: 3.479

Review 5.  Novel approaches to the management of noneosinophilic asthma.

Authors:  Neil C Thomson
Journal:  Ther Adv Respir Dis       Date:  2016-02-28       Impact factor: 4.031

6.  A large subgroup of mild-to-moderate asthma is persistently noneosinophilic.

Authors:  Kelly Wong McGrath; Nikolina Icitovic; Homer A Boushey; Stephen C Lazarus; E Rand Sutherland; Vernon M Chinchilli; John V Fahy
Journal:  Am J Respir Crit Care Med       Date:  2012-01-20       Impact factor: 21.405

7.  Heterogeneity of bronchitis in airway diseases in tertiary care clinical practice.

Authors:  Liesel D'silva; Nesreen Hassan; Hong-Yu Wang; Melanie Kjarsgaard; Ann Efthimiadis; Frederick E Hargreave; Parameswaran Nair
Journal:  Can Respir J       Date:  2011 May-Jun       Impact factor: 2.409

8.  Baseline sputum eosinophil + neutrophil subgroups' clinical characteristics and longitudinal trajectories for NHLBI Severe Asthma Research Program (SARP 3) cohort.

Authors:  Annette T Hastie; David T Mauger; Loren C Denlinger; Andrea Coverstone; Mario Castro; Serpil Erzurum; Nijar Jarjour; Bruce D Levy; Deborah A Meyers; Wendy C Moore; Brenda Phillips; Sally E Wenzel; John V Fahy; Elliot Israel; Eugene R Bleecker
Journal:  J Allergy Clin Immunol       Date:  2020-02-05       Impact factor: 10.793

Review 9.  Type 2 inflammation in asthma--present in most, absent in many.

Authors:  John V Fahy
Journal:  Nat Rev Immunol       Date:  2015-01       Impact factor: 53.106

10.  Treatment options in type-2 low asthma.

Authors:  Timothy S C Hinks; Stewart J Levine; Guy G Brusselle
Journal:  Eur Respir J       Date:  2021-01-21       Impact factor: 16.671
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.